new_0222_0475|VIRX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0475|VIRX|1|Viracta Therapeutics Inc Total Current Assets (Quarterly) (USD)|Viracta Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Viracta Therapeutics Inc Inventories (Quarterly) (USD)|Viracta Therapeutics Inc Net PP&E (Quarterly) (USD)|Viracta Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Viracta Therapeutics Inc Total Liabilities (Quarterly) (USD)|Viracta Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Viracta Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Viracta Therapeutics Inc Total Deposits (Quarterly) (USD)|Viracta Therapeutics Inc Book Value (Quarterly) (USD)|Viracta Therapeutics Inc Retained Earnings (Quarterly) (USD)|Viracta Therapeutics Inc Treasury Stock (Quarterly) (USD)|Viracta Therapeutics Inc EV to Revenues|Viracta Therapeutics Inc EV to Earnings|Viracta Therapeutics Inc EV to Free Cash Flow|Viracta Therapeutics Inc EV to Assets (Quarterly)|Viracta Therapeutics Inc PS Ratio|Viracta Therapeutics Inc PE Ratio|Viracta Therapeutics Inc Price to Book Value|Viracta Therapeutics Inc PEG Ratio|Viracta Therapeutics Inc Debt to Equity Ratio|Viracta Therapeutics Inc Dividend Yield|Viracta Therapeutics Inc Shareholder Yield (TTM)|Viracta Therapeutics Inc Percent of Shares Outstanding Short|Viracta Therapeutics Inc Total Receivables (Quarterly) (USD)|Viracta Therapeutics Inc Total Payables (Quarterly) (USD)|Viracta Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Viracta Therapeutics Inc Return on Invested Capital|Viracta Therapeutics Inc Quality Ratio Score|Viracta Therapeutics Inc Momentum Score|Viracta Therapeutics Inc Beta (1Y)|Viracta Therapeutics Inc Sustainable Growth Rate (TTM)|Viracta Therapeutics Inc Institutional Investor Ownership Percentage|Viracta Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Viracta Therapeutics Inc Total Employees (Annual)|Viracta Therapeutics Inc EPS Diluted (Quarterly) (USD)|Viracta Therapeutics Inc SG&A Expense (Quarterly) (USD)|Viracta Therapeutics Inc Shares Outstanding|Viracta Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Viracta Therapeutics Inc Ordinary Shares Number (Quarterly)|Viracta Therapeutics Inc Payout Ratio|Viracta Therapeutics Inc Quick Ratio (Quarterly)|Viracta Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Viracta Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Viracta Therapeutics Inc Effective Tax Rate (TTM)|Viracta Therapeutics Inc Return on Equity|Viracta Therapeutics Inc Net Income (TTM) (USD)|Viracta Therapeutics Inc Revenue (TTM) (USD)|Viracta Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Viracta Therapeutics Inc Revenue (Quarterly) (USD)|Viracta Therapeutics Inc Gross Profit (Quarterly) (USD)|Viracta Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Viracta Therapeutics Inc Net Income (Quarterly) (USD)|Viracta Therapeutics Inc Net Interest Income (Quarterly) (USD)|Viracta Therapeutics Inc Price (USD)|Viracta Therapeutics Inc Total Return Price (USD)|Viracta Therapeutics Inc Enterprise Value (USD)|Viracta Therapeutics Inc 30-Day Average Daily Volume|Viracta Therapeutics Inc 1 Year Price Returns (Daily)|Viracta Therapeutics Inc Short Interest|Viracta Therapeutics Inc PE Ratio (Forward)|Viracta Therapeutics Inc PE Ratio (Forward 1y)|Viracta Therapeutics Inc PS Ratio (Forward)|Viracta Therapeutics Inc PS Ratio (Forward 1y)|Viracta Therapeutics Inc Quarterly EPS Estimates (USD)|Viracta Therapeutics Inc Quarterly Revenue Estimates (USD)|Viracta Therapeutics Inc Quarterly EPS Surprise|Viracta Therapeutics Inc Quarterly Revenue Surprise|Viracta Therapeutics Inc Quarterly Actual EPS (USD)|Viracta Therapeutics Inc Quarterly Actual Revenue (USD)|Viracta Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Viracta Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Viracta Therapeutics Inc Price Target (USD)|Viracta Therapeutics Inc Consensus Recommendation|Viracta Therapeutics Inc Price Target Num Estimates|Viracta Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Viracta Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Viracta Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Viracta Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Viracta Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Viracta Therapeutics Inc Land and Improvements (Quarterly) (USD)|Viracta Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Viracta Therapeutics Inc Other Properties (Quarterly) (USD)|Viracta Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0475|VIRX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0475|VIRX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0475|VIRX|5|91.5|91.5||91.5||91.5|91.5|91.5||91.5|91.5||||1.44||||1.44|||1.43253968254||15.4090909091||91.5|91.5||||||30.6363636364|109.6||109.6|109.6|35.8571428571||91.5|||109.6|109.6|||91.5|||||109.6|109.6|109.6|1.43253968254|1.43253968254|1.44|1.43049327354||15.4090909091|||||91.4285714286|91.4285714286|91.5||91.5|91.5|31.7272727273|38.7777777778|34.9|12.4642857143|34.9|21.8125|26.8461538462|109.6|109.6|109.6|||91.5|||
new_0222_0475|VIRX|6|2|2||2||2|2|2||2|2||||225||||225|||252||22||2|2||||||11|5||5|5|7||2|||5|5|||2|||||5|5|5|252|252|225|223||22|||||7|7|2||2|2|11|9|10|28|10|16|13|5|5|5|||2|||
new_0222_0475|VIRX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0475|VIRX|202003||||||||||||||||||||||||||||||||||36.9946||-0.1194|1.011||||||-0.1194|||||||||-4.417|-4.417|0.04||||||||||||||||||||||||3.446|0.002|||||||
new_0222_0475|VIRX|202006||||||||||||||||||||||||||||||||||36.9946||-0.1145|0.879||||||-0.1145|||||||||-4.236|-4.236|0.004||||||||||||||||||||||||3.361|0.002|||||||
new_0222_0475|VIRX|202009||||||||||||||||||||||||||||||||||36.9946||-0.1103|0.887||||||-0.1103|-0.046||||||||-4.079|-4.079|-0.065||||||||||||||||||||||||3.105|0.011|0.066||||||
new_0222_0475|VIRX|202012||||||||||||||||||||||||1.7967|||||||||7.4629|||||36.9946|||||||||||||||||15.7|15.7||||664689|||||||||||||36|1|1|-0.88|-1.25|||||||||
new_0222_0475|VIRX|202103|132.304|129.181||1.078||11.465|6.265|5.2||119.292|-130.146||||-25.0014||||2.8718|||||1.7625||1.571|5.456||||||43.3423|15.1667||-5.22|3.84|37.0363||37.0363|||0.35|-62.317|||-91.963|||||-79.231|-79.231|-0.099|9.25|9.25|224.0628|347950.3667||652770|||||0.0233|4.5|-2432.4046|-100|-0.5442||4.5||40.5|1|2|-0.79|-1.155|4.024|0.016|0.105|||1.078||10.8|10.38
new_0222_0475|VIRX|202106|125.142|122.721||0.857||11.582|6.953|4.629||111.645|-139.316||||-25.8339||||3.7725|||||6.135||2.566|5.456||||||53.6138|37.2214||-0.25|3.871|37.1408||37.1408|||-0.2569|-0.002|||-96.716|||||-9.17|-9.17|-0.11|11.34|11.34|308.8957|474897.5333||2278604|||||-0.2367||-5.6323||-0.25||||33.5|1.25|4|-3.545|-1.3075|5.446|0.051|0.122|||0.857||10.52|9.22
new_0222_0475|VIRX|202109|113.015|110.983||0.987||12.565|7.161|5.404||98.523|-154.23||||-9.8589||||3.0348|||||3.0496||2.098|5.456||||||61.3737|37.3534|24|-0.4|3.711|37.2812||37.2812|||-0.2929|-0.001|||-107.394|||||-14.914|-14.914|-0.115|8.02|8.02|198.4902|166385.5||1136926|||||-0.31||5.7419||-0.2922||||33.5|1.25|4|-3.545|-1.315|7.088|0.052|0.125|||0.987||5.88|4.61
new_0222_0475|VIRX|202112|||||||||||||||-1.7723||||1.3823|||||2.2776|||||||||62.3795||||||||||||||||||||||3.65|3.65|35.6827|310161.4333||849799|||||-0.47||||||||28.8|1.25|5|-3.735|-1.35||||||||2.68|2.89
new_0222_0475|VIRX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.34|||||||||||||||||||||
new_0222_0475|VIRX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.355|||||||||||||||||||||
new_0222_0475|VIRX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.375|||||||||||||||||||||
new_0222_0475|VIRX|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.35|||||||||||||||||||||